130 likes | 242 Vues
This document outlines the role and responsibilities of the EMCDDA Scientific Committee as discussed by Henk Garretsen on February 14, 2008, in Palmela. The committee provides essential advice to the Management Board and director and can deliver opinions on any scientific aspects of EMCDDA activities. It undertakes both formal and voluntary tasks, reviews work programs, assesses new psychoactive substances, and collaborates in expert meetings. The recent evolution of the committee's structure emphasizes greater independence for its members and aims to enhance its engagement with EMCDDA's activities.
E N D
EMCDDA´s Scientific Committee Henk Garretsen, 14 February 2008, Palmela
Role of the Scientific Committee • SC advises MB and director • May deliver an opinion on any scientific aspect of the EMCDDA activities Henk Garretsen, 14 February 2008, Palmela
Structural tasks • Formal opinion on three year and annual work programmes • Reviewing Annual report package to check its scientific quality • Risk assessment of new psychoactive substances Henk Garretsen, 14 February 2008, Palmela
“Voluntary” tasks • Participation in (thematic) expert meetings, working groups • Bilateral advice in his/her field of expertise • Old SC - In some countries SC members advised National Focus Points for example on national reports. Henk Garretsen, 14 February 2008, Palmela
Personal note: we did all that but, not all members were very active Henk Garretsen, 14 February 2008, Palmela
Meetings of the Scientific Committee “Obligatory”: • Twice a year regular SC meetings • Ad hoc risk assessment meetings In general a high attendance rate “Voluntary”: • Expert meetings/working groups Just some SC members attended more than one meeting Henk Garretsen, 14 February 2008, Palmela
The role of the Chair and Vice chair • Also MB meetings, selection-committees senior staff, ad hoc committees (for instance steering group EMCDDA evaluation,Horizontal Drug Group (Chair: Last two years 10 visits to Lisbon and 6 to Brussels) Henk Garretsen, 14 February 2008, Palmela
Recent external evaluation: • SC is underused by the EMCDDA Henk Garretsen, 14 February 2008, Palmela
Possible reasons (personal view): • Not all SC members were very active/gave the impression that they want to be used • MB asked for the “formal opinions”, was not active in searching for more • EMCDDA staff are humans too: not all gave the impression that they want to have feedback. For some feedback may be seen as inconvenient Henk Garretsen, 14 February 2008, Palmela
New composition of the ScC, new start Old – New ScC • Old situation: 27 members (1 from each member state) • New situation: 15 members independent experts Henk Garretsen, 14 February 2008, Palmela
Advantages: • Members are independent • EMCDDA appoints the members and can decide on required expertise • EMCDDA may even discharge members if they don’t attend (enough) meetings Henk Garretsen, 14 February 2008, Palmela
Role SC in the past (and future?): • Role of “critical friend” • Understanding the evolution of EMCDDA – sense of reality – • don’t always judge EMCDDA activities by comparing them with a golden standard but work towards a situation that it is actually possible to do so in the future Henk Garretsen, 14 February 2008, Palmela
Informal interactions Old SC: • Sometimes dinner all together (if so on initiative of EMCDDA) • Some interaction in subgroups New SC? Henk Garretsen, 14 February 2008, Palmela